Chipscreen(SH:688321) Xin Lang Cai Jing·2025-09-09 06:21Company Overview - Microchip Biotech Co., Ltd. is located in Shenzhen, Guangdong Province, and was established on March 21, 2001. The company went public on August 12, 2019. Its main business involves providing affordable, urgently needed innovative molecular entity drugs for patients [1]. - The revenue composition of the company is as follows: 97.80% from product sales, 1.81% from other (supplementary) sources, 0.27% from technology licensing, and 0.13% from other sources [1]. Stock Performance - On September 9, Microchip Biotech's stock fell by 5.08%, trading at 34.74 yuan per share, with a transaction volume of 416 million yuan and a turnover rate of 2.83%. The total market capitalization is 14.167 billion yuan [1]. Fund Holdings - According to data from the top ten holdings of funds, one fund under Minsheng Jianyin has a significant position in Microchip Biotech. The Minsheng Jianyin Selected Mixed Fund (690003) reduced its holdings by 16,300 shares in the second quarter, now holding 61,000 shares, which accounts for 3.98% of the fund's net value, ranking as the ninth largest holding [2]. - The Minsheng Jianyin Selected Mixed Fund (690003) was established on February 3, 2010, with a latest scale of 36.408 million yuan. Year-to-date returns are 47.17%, ranking 685 out of 8179 in its category, while the one-year return is 70.55%, ranking 1221 out of 7984. Since inception, the fund has experienced a loss of 34.51% [2]. Fund Manager Profile - The fund manager of Minsheng Jianyin Selected Mixed Fund (690003) is Liu Xiaohan, who has a cumulative tenure of 15 years and 118 days. The total asset size of the fund is 71.9225 million yuan, with the best return during his tenure being 91.63% and the worst return being -36.36% [3].